|Day Low/High||27.25 / 28.02|
|52 Wk Low/High||16.56 / 29.44|
Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Horizon Pharma plc ("Horizon" or the "Company") (NASDAQ: HZNP).
Drugmaker Endo and partner BioDelivery Sciences have a key pipeline event coming soon, possibly tomorrow.
Goldberg Law PC ( http://www.Goldberglawpc.
Horizon Pharmaceutical (HZNP) stock is declining in afternoon trading, as it and Valeant Pharmaceuticals are scrutinized for their use of specialty pharmacies.
Short-selling research firm Citron Research claims Philidor Rx and R&O, which both have links to Valeant VRX, are the same company and share management...
Levi & Korsinsky, LLP announces that it has commenced an investigation of Horizon Pharma plc ("Horizon Pharma" or the "Company") (NASDAQGS:HZNP) concerning possible violations of federal securities laws by the Company...
If you ask Jim Cramer (and social media users did), Microsoft should acquire Salesforce, IBM should grab Box, pharmaceuticals have a political problem, and there's no substitute for Berkshire Hathaway.
Jim Cramer says Microsoft (MSFT) will report a decent quarter, thanks to Windows 10, but he wishes the company would make an acquisition.
Trade-Ideas LLC identified Horizon Pharma (HZNP) as a strong on high relative volume candidate
A so-called "pyramid strategy" can help you enter the depressed sector.
Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate
Stocks get cheaper as they head lower and every day we're inching closer to a bottom, Cramer says.
Trade-Ideas LLC identified Horizon Pharma (HZNP) as a weak on high relative volume candidate
Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "dead cat bounce" (down big yesterday but up big today) candidate
Materials and technology names led the way down on the session.
Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate
Analysts at research firms Jefferies and Piper Jaffray are recommending select biotech stocks that they view as buys amid the weakness in the space.
Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
The pharma companies faced off in Calfironia over Horizon's rejected $2 billion hostile takeover.
The offer comes just three months after Depomed purchases the diabetes-related pain drug Nucynta from a subsidiary of Johnson & Johnson.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.